MedTrace Logo

Continuous Temperature Monitoring for tHe Early Recognition of Febrile Neutropenia in Haematological MALignancies

NCT05203809 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2022-01-24

No results posted yet for this study

Summary

The THERMAL study is a pilot study to determine feasibility of using two separate continuous skin temperature monitors during intensive treatment for haematological malignancies. It involves participants wearing both the TempTraq and CORE temperature devices for up to 14 days, and then assessing their feasibility and tolerability with quantitative, semiquantitative and qualitative methods.

Conditions

Interventions

DEVICE

TempTraq temperature monitor

All participants will wear both TempTraq temperature monitor and CORE temperature monitor.

Sponsors & Collaborators

  • Malaghan Institute of Medical Research

    lead OTHER

Eligibility

Min Age
16 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-18
Primary Completion
2022-06-30
Completion
2022-06-30
FDA Device
Yes

Countries

  • New Zealand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05203809 on ClinicalTrials.gov